Search Results - "UPRICHARD, J."

Refine Results
  1. 1

    Ongoing risk of thrombosis with factor XI concentrate: 5 years experience in two centres by Batty, P., Honke, A., Bowles, L., Hart, D. P., Pasi, K. J., Uprichard, J., Austin, S. K.

    “…Introduction Factor XI (FXI) deficiency is the commonest of the rare bleeding disorders, affecting 2079 individuals in the United Kingdom. Treatment options…”
    Get full text
    Journal Article
  2. 2
  3. 3

    The impact of providing blood to the scene of an accident on transfusion laboratory practice by Wolf, S., Morris, J., Kennedy, K., Lawn, M., Mcloughlin, T., Feane, K., Uprichard, J., Weaver, A., Allard, S., Green, L.

    Published in Transfusion medicine (Oxford, England) (01-02-2018)
    “…SUMMARY Background Haemorrhage is the leading cause of mortality during trauma. In 2012, London's Air Ambulance introduced Blood on Board (BOB), transfusing…”
    Get full text
    Journal Article
  4. 4

    Factor IX replacement to cover total knee replacement surgery in haemophilia B: a single-centre experience, 2000-2010 by UPRICHARD, J., ADAMIDOU, D., GODDARD, N. J., MANN, H. A., YEE, T. T.

    “…Total knee replacement (TKR) is a well recognized treatment for haemophilic arthropathy. Successful haemostasis can be achieved by bolus doses or continuous…”
    Get full text
    Journal Article
  5. 5

    Use of thromboelastography to assess the combined role of pregnancy and obesity on coagulation: a prospective study by Sharma, S, Uprichard, J, Moretti, A, Boyce, H, Szydlo, R, Stocks, G

    “…Abstract Background Thromboelastography (TEG®) is a point of care monitor of whole blood coagulation and has previously demonstrated hypercoagulability in both…”
    Get full text
    Journal Article
  6. 6

    Lower Uterine Segment Placental Thickness in Women With Abnormally Invasive Placenta by Bhide, A, Laoreti, A, Agten, A.K, Papageorghiou, A, Khalil, A, Uprichard, J, Thilaganathan, B, Chandraharan, E

    Published in Obstetric anesthesia digest (01-12-2019)
    “…(Acta Obstet Gynecol Scand. 2019;98:95–100)Although uncommon, abnormally invasive placentation (AIP) is associated with adverse maternal outcomes, including…”
    Get full text
    Journal Article
  7. 7

    Haemopoietic stem cell transplantation induces tolerance to donor antigens but not to foreign FVIII peptides by UPRICHARD, J., DAZZI, F., APPERLEY, J. F., LAFFAN, M. A.

    “…A 22‐year‐old male with severe haemophilia A and high responding factor VIII (FVIII) inhibitor underwent sibling haematopoietic stem cell transplantation in an…”
    Get full text
    Journal Article
  8. 8

    British Society of Haematology, Slide Session presented at the Annual Scientific Meeting, Brighton 2009 by McLORNAN, D. P., BURTHEM, J., DUNCOMBE, A., HATTON, C., HUTCHINSON, C. V., MARSDEN, K., MACARTNEY, C. M., SMITH-STRANEY, T., UPRICHARD, J., WALLIS, J., WEBB, S., WILKINS, B. S., McMULLIN, M. F.

    “…Summary Seven cases were discussed by an expert panel at the 2009 Annual Scientific Meeting of the British Society of Haematology. These cases are presented in…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Investigating microcytic anaemia by Uprichard, W Owen, Uprichard, James

    Published in BMJ (Online) (07-06-2013)
    “…This article explores how to assess the common causes of microcytic anaemia…”
    Get full text
    Journal Article
  12. 12

    Phase I Trial of PT-100 (PT-100), A Cytokine-Inducing Small Molecule, Following Chemotherapy for Solid Tumor Malignancy by Nemunaitis, John, Vukelja, Svetislava J., Richards, Donald, Cunningham, Casey, Senzer, Neil, Nugent, John, Duncan, Houston, Jones, Barry, Haltom, Eric, Uprichard, Margaret J.

    Published in Cancer investigation (01-01-2006)
    “…PT-100 upregulates cytokine expression competitively inhibiting the dipeptidyl peptidase activity of fibroblast activation protein (FAP) and dipeptidyl…”
    Get full text
    Journal Article
  13. 13

    Factor X deficiency by Uprichard, James, Perry, David J.

    Published in Blood reviews (01-06-2002)
    “…Factor X is one of the vitamin K-dependent serine proteases. It plays a crucial role in the coagulation cascade, as the first enzyme in the common pathway of…”
    Get full text
    Journal Article
  14. 14

    Gene mutations and three‐dimensional structural analysis in 13 families with severe factor X deficiency by Peyvandi, Flora, Menegatti, Marzia, Santagostino, Elena, Akhavan, Sepideh, Uprichard, James, Perry, David J., Perkins, Stephen J., Mannucci, Pier M.

    Published in British journal of haematology (01-06-2002)
    “…Factor X (FX) deficiency is a rare autosomal recessive disorder. The phenotype and genotype of 15 Iranian patients with FX deficiency from 13 unrelated…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Investigating suspected anaemia by Uprichard, James, Bain, Barbara J

    Published in BMJ (22-05-2009)
    “…Often a blood count only is not sufficient for prompt diagnosis of suspected anaemia. This article details the additional tests that should be performed…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Hepatitis C virus cures after direct acting antiviral-related drug-induced liver injury: Case report by Hasin, Yaakov, Shteingart, Shimon, Dahari, Harel, Gafanovich, Inna, Floru, Sharon, Braun, Marius, Shlomai, Amir, Verstandig, Anthony, Dery, Ilana, Uprichard, Susan L, Cotler, Scott J, Lurie, Yoav

    Published in World journal of hepatology (18-07-2016)
    “…The United States Food and Drug Administration recently warned that the direct acting antiviral(DAA) combination hepatitis C virus(HCV) treatment of…”
    Get full text
    Journal Article
  19. 19

    Phase 1 Rising Multiple-Dose Study of Talabostat (PT-100) in Healthy Subjects by Uprichard, Margaret J., Jones, Barry

    Published in Blood (16-11-2004)
    “…Background: Talabostat (PT-100) is an orally available small molecule that competitively inhibits dipeptidyl peptidases such as DPP-IV/CD26 and fibroblast…”
    Get full text
    Journal Article
  20. 20

    Phase 2 study of talabostat/gemcitabine in Stage IV pancreatic cancer by Nugent, F. W., Cunningham, C., Barve, M. A., Fisher, W., Patel, H., Meiri, E., Oza, Y. V., Yang, Z., Jurkowski, E. C., Uprichard, M. J.

    Published in Journal of clinical oncology (20-06-2007)
    “…Abstract only 4616 Background: Talabostat is an oral small molecule inhibitor of fibroblast activation protein (FAP), a stromal enzyme with collagenase and…”
    Get full text
    Journal Article